Return to homepagePandemic Pact

Association of Intestinal Dysbiosis with Clinical Outcomes in COVID-19 Patients

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    -99

  • Known Financial Commitments (USD)

    $0

  • Funder

    University of Minnesota

  • Principal Investigator

    MD. Alexander Khoruts

  • Research Location

    United States of America

  • Lead Research Institution

    Medical School, University of Minnesota

  • Research Priority Alignment

    N/A

  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Pathogen morphology, shedding & natural history

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Led by Alexander Khoruts, MD, professor, Department of Medicine, researchers in this study will collect fecal swabs from hospitalized COVID-19 patients to characterize: bacterial diversity identity and classification of microorganisms presence of SARS-CoV-2 RNA These data will be used in the design of an interventional clinical trial. "Our program is the world leader in development of restorative microorganism therapeutics," said Khoruts. "Therefore, we are in a unique position to develop clinical trials that can mitigate untoward effects of antibiotics in immune response."